Difficulty: Medium
Average Score: 88%
Practice
The commonest cause of non-thrombocytopenic purpura in children is:
Correct answer
B
Rationale
In pediatric nursing, understanding the various causes of purpura is crucial for accurate assessment and diagnosis. The correct answer, B) Anaphylactoid purpura, is the commonest cause of non-thrombocytopenic purpura in children. This condition, also known as Henoch-Sch├Ânlein purpura, is characterized by immune-mediated inflammation of small blood vessels, leading to purpuric rash, joint pain, abdominal pain, and kidney involvement.
Option A) Disseminated intravascular hemolysis (DIC) is incorrect because it is a cause of thrombocytopenic purpura due to platelet consumption in the coagulation process. Option C) Acute lymphoblastic leukemia is incorrect as it is associated with thrombocytopenia rather than non-thrombocytopenic purpura. Option D) Hypersplenism is also incorrect because it results in splenic sequestration of platelets leading to thrombocytopenia.
Educationally, this question highlights the importance of recognizing different types of purpura in children and understanding the underlying pathophysiology to provide appropriate care. Nurses should be able to differentiate between thrombocytopenic and non-thrombocytopenic purpura to guide treatment interventions and ensure optimal outcomes for pediatric patients.
Option A) Disseminated intravascular hemolysis (DIC) is incorrect because it is a cause of thrombocytopenic purpura due to platelet consumption in the coagulation process. Option C) Acute lymphoblastic leukemia is incorrect as it is associated with thrombocytopenia rather than non-thrombocytopenic purpura. Option D) Hypersplenism is also incorrect because it results in splenic sequestration of platelets leading to thrombocytopenia.
Educationally, this question highlights the importance of recognizing different types of purpura in children and understanding the underlying pathophysiology to provide appropriate care. Nurses should be able to differentiate between thrombocytopenic and non-thrombocytopenic purpura to guide treatment interventions and ensure optimal outcomes for pediatric patients.